Shares of Walgreens Boots Alliance (NASDAQ: WBA) rocketed 27.5% higher on Friday, Jan. 10, 2024. Investors of all stripes are wondering whether more gains could be ahead for the beaten-down retail pharmacy chain operator.

We recently compiled a list of the Best Medical Stocks To Buy Under $20. In this article, we are going to take a look at where Walgreens Boots Alliance, Inc. (NASDAQ:WBA) stands against the other best medical stocks under $20.

After a dreadful 2024 that saw its stock lose more than 60% of its value, 2025 has started off as a better year for Walgreens Boots Alliance (NASDAQ: WBA), with the stock skyrocketing after the pharmacy operator announced better-than-expected fiscal Q1 2025 results for the period ended November 2024.

Walgreens was the worst stock in the S&P 500 last year. An analyst writes that it’s still “premature to say that Walgreens is on a stable path to growth” despite upbeat earnings.

Walgreens Boots Alliance posted a wider quarterly loss, hit by the costs of closing stores and weaker retail sales, but shares surged after a smaller-than-expected drop in adjusted earnings. Walgreens shares soared more than 28% to$11.

Key Takeaways Walgreens shares jumped Friday morning after the retailer recorded better sales and adjusted profits than analysts had expected.Revenue rose from last year, while the company recorded a larger net loss than expected as it starts a turnaround plan that includes closing 1,

Walgreens Boots Alliance (NASDAQ:WBA) shares are gaining ground in Friday’s premarket trading as the company’s effort to trim costs and turn the company around begins to gain traction, demonstrated by upbeat fiscal Q1 results and top-line,